APPLICATIONS PUBLISHED 27 APRIL 2005

Novel floating dosage form
Cadila Healthcare 1524963*

Process for the preparation of crystalline nano-particle dispersions
AstraZeneca 1524964*

Stabilisation of the profile of release of active substances from a formulation
LEK farmacevtska druzba 1524965*

Taste masked oral compsn of telithromycin
Aventis Pharma 1524966*

Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
Ratiopharm 1524967*

Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility
Flamel Technologies 1524968*

Microcapsules with modified release of active principles with low solubility for oral delivery
Flamel Technologies 1524969*

Particles which are surface coated with hyaluronan or one of its derivatives thereof and the use of same as biological vectors for active substances
Centre National de la Recherche Scientifique 1524970*

Improved transdermal delivery system
Schwartz Pharma 1524971*

Compounds with antiparasitic activity and medicines containing same
Centre National de la Recherche Scientifique 1524972*

A pharmaceutical compsn useful for treating chronic myeloid leukaemia
Council of Scientific and Industrial Research 1524974*

Transcription factor modulating compounds and methods of use thereof
Paratek Pharmaceuticals 1524974*

Improved transdermal delivery system for the administration of rotigotine
Schwartz Pharma 1524975*

A non-hormonal approach to male contraception
Unither Pharmaceuticals 1524976*

Use of a preoteasome inhibitor in the treatment of endothelial dysfunction and/or in a low dose proteasome inhibitor therapy
Charite- Universitaetsmedizin Berlin 1524977*

Taste masked sumitriptan tablets and processes for their preparation
Ranbaxy Laboratories 1524978*

New effector conjugates, process for their preparation and their pharmaceutical use
Schering 1524979*

Phenylalanine enamide derivatives containing a spiro(,35)non-1-ene ring for use as integrin inhibitors
Celltech R&D 1524980*

Sustained release formulations comprising lamotrigine
Glaxo Group 1524981*

Medicament and method for reducing alcohol and/or tobacco consumption
HF Arzneimittelforschung 1524982*

Compsn containing an androgenous 11-beta halogen steroid and a progestational hormone, and male contraceptive based on said compsn
Schering 1524983*

Myocardial perfusion imaging using A2A receptor agonists
CV Therapeutics 1524984*

Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs
Phenion 1524985*

Metal cluster nanocompounds for treating tumour diseases
Universitaet Duisberg-Essen 1524986*

Nasal peptide pharmaceutical formulation
Therapicon 1524987*

Use of a proteasome inhibitor in the treatment of fibrotic diseases
Charite-Universitaetmedizin Berlin 1524988*

Method and compsn for protecting neuronal tissue from damage induced by elevated glutamate levels
Yeda Research and Development 1524989*

Vaccine compsn comprising lipooligosaccharide with reduced phase variability
GlaxoSmithKline Biologicals; The University of Queensland 1524990*

Vaccine compsn comprising transferrin binding protein and HSF from gram-negative bacteria
GlaxoSmithKline Biologicals 1524991*

Vaccine compsns comprising L2 and/or L3 immunotype lipoligosaccharides from LGTB-neisseria minigitidis
GlaxoSmithKline Biologicals 1524992*

Neisserial vaccine compsns comprising a combination of antigens
GlaxoSmithKline Biologicals 1524993*

Vaccine compsns containing amyloid beta-1,6 antigen arrays
Cytos Biologicals 1524994*

Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
Wliex 1524995*

Combination of PDE5 inhibitors with angiotensin II receptor antagonists
Pfizer 1524996*

Stable liquid prenteral parcoxib formulation
Pharmacia 1524997*

Stable pharmaceutical compsn comprising erythropoietin
LEK Pharmaceuticals 1524998*

Synthetic anti-Candida albicans oligosaccharide based vaccines
Bundle, David; Nitz, Mark; Cutler, Jim 1524999*

Gastrointestinal delivery of genetic material coupled to a transporting agent
Neox 1525000*

Conjugates of porphyrin compounds with chemotherapeutic agents
Cleegate 1525001*

Method for the synthesis of anthracycline-peptide conjugates
Universite Catholique de Louvain; Diatos 1525002*

Methods and contrast agents useful in quantifying nitric oxide
Pharmacia 1525003*

Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PTC Therapeutics; Tularik 1525185*

Inhibitors of HCV NS5B polymerase
Pharmacia & Upjohn 1525186*

Process for increasing the capacity of a urea plant
SM 1525187*

Novel derivatives of 4,4"-dithiobis-(3-aminobutane-1-sulphonates) and compsns containing same
Institut National de la Sante et de la Recherche Medicale 1525188*

Crystalline polymorphic and amorphous forms of benazepril hydrochloride
Ciba Specialty Chemicals 1525189*

CCK-1 receptor modulators
Janssen Pharmaceutica 1525190*

Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives
Laboratoires Mayoly Spindler; Centre National de la Recherche Scientifique; Universite Montpelier II 1525191*

Co-surfactants based on aldehydes
BASF 1525192*

Acetylaminothiazole derivatives, preparation and therapeutic use thereof
Sanofi-Aventis 1525193*

Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
Euro-Celtique 1525194*

Method for the production of phenylalanine derivatives
Wilex 1525195*

Pyridyl-triazine derivatives as microbicidal active substances
Ciba Specialty Chemicals 1525196*

Method for producing highly pure hydroxy indolyl glycoxylic acid amides
Elbion 1525197*

Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
Sanofi-Aventis 1525198*

Substituted thienyl-hydroxamic acids as histone deacetylease inhibitors
Argenta Discovery 1525199*

2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-Kit inhibitors
AV Science 1525200*

Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
Pfizer Products 1525201*

Novel 2,5-disubstituted pyrimidine derivatives
Bayer HealthCare 1525202*

4-amino-substituted pyrimidine derivatives
Bayer HealthCare 1525203*

Phenylalanine enamide derivatives
Celltech 1525204*

Novel substituted pyrazolo(1,5A0-1m3m5-triazone derivatives and their analogues, pharmaceutical compsns containing same, use thereof as medicine and methods for preparing same
Greenpharma 1525205*

Polyaminomethylenephosphonate derivatives
Giovanni Bozzetto 1525206*

Process for purification of zoledronic acid
Teva Pharmaceutical Industries 1525207*

Novel difluorinated gem compounds, preparation methods thereof and applications of same
Institut National des Sciences Appliquees de Rouen 1525208*

1"-, 2"- and 3"-modified nucleoside derivatives for treating flaviridae infections
Idenix (Cayman), Centre National de la Recherche Scientifique, Universita Degli Studi di Cagliari 1525209*

Methods for making biochips
Centre National de la Recherche Scientifique; Universite de Nantes; University of Florida 1525210*

Fluorescent entity comprising a fluorophore covalently attached to at least one functional group; and uses thereof
Cis Bio International 1525211*

Method for preparing oligonucleotides
Girindus; Centre National de la Recherche Scientifique; L"Universite Montpellier II 1525212*

Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
National Jewish Medical and Research Centre 1525213*

Process and new intermediates for the preparation of steroids with a progestogen activity
Poli Industria Chimica 1525214*

Progesterone receptor modulators having an increased antigonadotrophic activity for use in female fertility testing and hormone replacement therapy
Schering 1525215*

Combination therapy for treatment of HIV infection
Sangstat Medical 1525216*

Plant peptide with antimicrobial activity
Centre National de la Recherche Scientifique 1525217*

Bicyclic oligopeptides and their use as glucagon receptor antagonists
Boehringer Ingelheim Pharma 1525218*

GLP-1 and methods for treating diabetes
Zealand Pharma 1525219*

Splice variant cannabinoid receptor (CB1B)
AstraZeneca 1525220*